CXCL1 microspheres: a novel tool to stimulate arteriogenesis

References

• Andres-Guerrero V, Zong M, Ramsay E, et al. (2015). Novel biodegradable polyesteramide microspheres for controlled drug delivery in ophthalmology. J Control Release 211:105–17
   PubMed Web of Science ®Google Scholar
• Bala I, Hariharan S, Kumar MN. (2004). PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 21:387–422
   PubMed Web of Science ®Google Scholar
• Bastiaansen AJ, Ewing MM, de Boer HC, et al. (2013). Lysine acetyltransferase PCAF is a key regulator of arteriogenesis. Arterioscler Thromb Vasc Biol 33:1902–10
   PubMed Web of Science ®Google Scholar
• Benjamin LE, Golijanin D, Itin A, et al. (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103:159–65
   PubMed Web of Science ®Google Scholar
• Cao Y, Hong A, Schulten H, Post MJ. (2005). Update on therapeutic neovascularization. Cardiovasc Res 65:639–48
   PubMed Web of Science ®Google Scholar
• Chandraratne S, von Bruehl ML, Pagel JI, et al. (2015). Critical role of platelet glycoproteinibα in arterial remodeling. Arterioscler Thromb Vasc Biol 35:589–97
   PubMed Web of Science ®Google Scholar
• De Backer G, Ambrosioni E, Borch-Johnsen K, et al. (2004). European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis 173:381–91
   PubMed Web of Science ®Google Scholar
• Deindl E, Schaper W. (2005). The art of arteriogenesis. Cell Biochem Biophys 43:1–15
   PubMed Web of Science ®Google Scholar
• Deng M, Wu J, Reinhart-King CA, Chu CC. (2011). Biodegradable functional poly(ester amide)s with pendant hydroxyl functional groups: synthesis, characterization, fabrication and in vitro cellular response. Acta Biomater 7:1504–15
   PubMed Web of Science ®Google Scholar
• Diwan M, Park TG. (2003). Stabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheres. Int J Pharm 252:111–22
   PubMed Web of Science ®Google Scholar
• dos Santos DF, Nicolete R, de Souza PR, et al. (2009). Characterization and in vitro activities of cell-free antigens from Histoplasma capsulatum-loaded biodegradable microspheres. Eur J Pharm Sci 38:548–55
   PubMed Web of Science ®Google Scholar
• Eitenmuller I, Volger O, Kluge A, et al. (2006). The range of adaptation by collateral vessels after femoral artery occlusion. Circ Res 99:656–62
   PubMed Web of Science ®Google Scholar
• Fischer C, Schneider M, Carmeliet P. (2006). Principles and therapeutic implications of angiogenesis, vasculogenesis and arteriogenesis. Handb Exp Pharmacol 157–212
   PubMedGoogle Scholar
• Fonseca AC, Gil MH, Simoes PN. (2014). Biodegradable poly(ester amide)s – a remarkable opportunity for the biomedical area: review on the synthesis, characterization and applications. Prog Polym Sci 39:1291–311
   Web of Science ®Google Scholar
• Freitas S, Merkle HP, Gander B. (2005). Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release 102:313–32
   PubMed Web of Science ®Google Scholar
• Ghaffar A, Draaisma GJ, Mihov G, et al. (2011). Monitoring the in vitro enzyme-mediated degradation of degradable poly(ester amide) for controlled drug delivery by LC-ToF-MS. Biomacromolecules 12:3243–51
   PubMed Web of Science ®Google Scholar
• Guo K, Chu CC. (2009). Biodegradable and injectable paclitaxel-loaded poly(ester amide)s microspheres: fabrication and characterization. J Biomed Mater Res Part B – Appl Biomater 89B:491–500
   Web of Science ®Google Scholar
• Hackam DG, Anand SS. (2003). Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA 290:932–40
   PubMed Web of Science ®Google Scholar
• Hagiwara H, Mitsumata M, Yamane T, et al. (1998). Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. Circulation 98:2584–90
   PubMed Web of Science ®Google Scholar
• Heil M, Eitenmuller I, Schmitz-Rixen T, Schaper W. (2006). Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 10:45–55
   PubMed Web of Science ®Google Scholar
• Helisch A, Schaper W. (2003). Arteriogenesis: the development and growth of collateral arteries. Microcirculation 10:83–97
   PubMed Web of Science ®Google Scholar
• Hellingman AA, Bastiaansen AJ, de Vries MR, et al. (2010). Variations in surgical procedures for hind limb ischaemia mouse models result in differences in collateral formation. Eur J Vasc Endovasc Surg 40:796–803
   PubMed Web of Science ®Google Scholar
• Hernandez KA, Hooper RC, Boyko T, et al. (2015). Reduction of suture associated inflammation after 28 days using novel biocompatible pseudoprotein poly(ester amide) biomaterials. J Biomed Mater Res Part B Appl Biomater 103:457–63
   PubMed Web of Science ®Google Scholar
• Heuslein JL, Meisner JK, Li X, et al. (2015). Mechanisms of amplified arteriogenesis in collateral artery segments exposed to reversed flow direction. Arterioscler Thromb Vasc Biol 35:2354–65
   PubMed Web of Science ®Google Scholar
• Hoefer IE, Grundmann S, van Royen N, et al. (2005). Leukocyte subpopulations and arteriogenesis: specific role of monocytes, lymphocytes and granulocytes. Atherosclerosis 181:285–93
   PubMed Web of Science ®Google Scholar
• Jain RK. (2003). Molecular regulation of vessel maturation. Nat Med 9:685–93
   PubMed Web of Science ®Google Scholar
• Keeley EC, Mehrad B, Strieter RM. (2008). Chemokines as mediators of neovascularization. Arterioscler Thromb Vasc Biol 28:1928–36
   PubMed Web of Science ®Google Scholar
• Knight DK, Gillies ER, Mequanint K. (2011). Strategies in functional poly(ester amide) syntheses to study human coronary artery smooth muscle cell interactions. Biomacromolecules 12:2475–87
   PubMed Web of Science ®Google Scholar
• Lee JS, Frevert CW, Wurfel MM, et al. (2003). Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo. J Immunol 170:5244–51
   PubMed Web of Science ®Google Scholar
• Lei L, Wang S, Wu H, et al. (2015). Optimization of release pattern of FGF-2 and BMP-2 for osteogenic differentiation of low-population density hMSCs. J Biomed Mater Res A 103:252–61
   PubMed Web of Science ®Google Scholar
• Levi F, Lucchini F, Negri E, La Vecchia C. (2002). Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 88:119–24
   PubMed Web of Science ®Google Scholar
• Mangiafico RA, Fiore CE. (2009). Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies. Curr Vasc Pharmacol 7:394–413
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Burke PA, Langer R. (2014). Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov 13:655–72
   PubMed Web of Science ®Google Scholar
• Nowak WN, Mika P, Nowobilski R, et al. (2012). Exercise training in intermittent claudication: effects on antioxidant genes, inflammatory mediators and proangiogenic progenitor cells. Thromb Haemost 108:824–31
   PubMed Web of Science ®Google Scholar
• Olin JW, Sealove BA. (2010). Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc 85:678–92
   PubMed Web of Science ®Google Scholar
• Ouriel K. (2001). Peripheral arterial disease. Lancet 358:1257–64
   PubMed Web of Science ®Google Scholar
• Pai SS, Tilton RD, Przybycien TM. (2009). Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery. AAPS J 11:88–98
   PubMed Web of Science ®Google Scholar
• Pruenster M, Mudde L, Bombosi P, et al. (2009). The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 10:101–8
   PubMed Web of Science ®Google Scholar
• Richardson RM, Marjoram RJ, Barak LS, Snyderman R. (2003). Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J Immunol 170:2904–11
   PubMed Web of Science ®Google Scholar
• Richardson RM, Pridgen BC, Haribabu B, et al. (1998). Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J Biol Chem 273:23830–6
   PubMed Web of Science ®Google Scholar
• Roy RS, Roy B, Sengupta S. (2011). Emerging technologies for enabling proangiogenic therapy. Nanotechnology 22:494004
   PubMed Web of Science ®Google Scholar
• Said SS, Pickering JG, Mequanint K. (2014). Controlled delivery of fibroblast growth factor-9 from biodegradable poly(ester amide) fibers for building functional neovasculature. Pharm Res 31:3335–47
   PubMed Web of Science ®Google Scholar
• Scholz D, Ziegelhoeffer T, Helisch A, et al. (2002). Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 34:775–87
   PubMed Web of Science ®Google Scholar
• Semenza GL. (2007). Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem 102:840–7
   PubMed Web of Science ®Google Scholar
• Shimizu S. (2004). Routes of administration. In: Hedrich H, ed. The laboratory mouse. London: Elsevier Academic Press
   Google Scholar
• Sinha VR, Trehan A. (2003). Biodegradable microspheres for protein delivery. J Control Release 90:261–80
   PubMed Web of Science ®Google Scholar
• Smith DF, Galkina E, Ley K, Huo Y. (2005). GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol 289:H1976–84
   PubMed Web of Science ®Google Scholar
• Sun H, Cheng R, Deng C, et al. (2015). Enzymatically and reductively degradable α-amino acid-based poly(ester amide)s: synthesis, cell compatibility, and intracellular anticancer drug delivery. Biomacromolecules 16:597–605
   PubMed Web of Science ®Google Scholar
• Tarvainen T, Karjalainen T, Malin M, et al. (2002). Degradation of and drug release from a novel 2,2-bis(2-oxazoline) linked poly(lactic acid) polymer. J Control Release 81:251–61
   PubMed Web of Science ®Google Scholar
• Teunissen PF, Boshuizen MC, Hollander MR, et al. (2015). MAb therapy against the IFN-alpha/beta receptor subunit 1 stimulates arteriogenesis in a murine hindlimb ischaemia model without enhancing atherosclerotic burden. Cardiovasc Res 107:255–66
   PubMed Web of Science ®Google Scholar
• van Royen N, Hoefer I, Bottinger M, et al. (2003). Local monocyte chemoattractant protein-1 therapy increases collateral artery formation in apolipoprotein E-deficient mice but induces systemic monocytic CD11b expression, neointimal formation, and plaque progression. Circ Res 92:218–25
   PubMed Web of Science ®Google Scholar
• Vera M, Puiggali J, Coudane J. (2006). Microspheres from new biodegradable poly(ester amide)s with different ratios of l- and d-alanine for controlled drug delivery. J Microencapsul 23:686–97
   PubMed Web of Science ®Google Scholar
• Vries MH, Wagenaar A, Verbruggen SE, et al. (2015). CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space. Angiogenesis 18:163–71
   PubMed Web of Science ®Google Scholar
• Wolf C, Cai WJ, Vosschulte R, et al. (1998). Vascular remodeling and altered protein expression during growth of coronary collateral arteries. J Mol Cell Cardiol 30:2291–305
   PubMed Web of Science ®Google Scholar